Prevnar News and Research

RSS
Pfizer responds to CDC’S ACIP discussion related to use of Prevnar 13 in adults over 50

Pfizer responds to CDC’S ACIP discussion related to use of Prevnar 13 in adults over 50

Pfizer’s Prevenar 13 gets US approval for adults

Pfizer’s Prevenar 13 gets US approval for adults

FDA approves Prevnar 13 pneumococcal conjugate vaccine for adults 50 and older

FDA approves Prevnar 13 pneumococcal conjugate vaccine for adults 50 and older

FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine as a single dose for adults

FDA approves Pfizer's Prevnar 13 pneumococcal conjugate vaccine as a single dose for adults

Pfizer enters Prevenar 13 supply agreement to protect children from pneumococcal disease

Pfizer enters Prevenar 13 supply agreement to protect children from pneumococcal disease

Pneumococcal vaccine Prevnar13 effective in seniors

Pneumococcal vaccine Prevnar13 effective in seniors

Pfizer's Prevnar 13: Additional data from adult clinical studies presented at 49th IDSA

Pfizer's Prevnar 13: Additional data from adult clinical studies presented at 49th IDSA

Pfizer second-quarter revenues decrease 1% to $17.0 billion

Pfizer second-quarter revenues decrease 1% to $17.0 billion

FDA issues 90-day extension for Pfizer's Prevnar 13 sBLA to treat pneumonia in adults

FDA issues 90-day extension for Pfizer's Prevnar 13 sBLA to treat pneumonia in adults

Merck and Sanofi Pasteur commence Phase III trial of pediatric hexavalent combination vaccine

Merck and Sanofi Pasteur commence Phase III trial of pediatric hexavalent combination vaccine

EvaluatePharma data shows poor R&D productivity measures both in quality, quantity

EvaluatePharma data shows poor R&D productivity measures both in quality, quantity

Researchers develop new pneumococcal vaccine through novel discovery approach

Researchers develop new pneumococcal vaccine through novel discovery approach

Pfizer seeks FDA and EMA approval for expanded use of Prevnar 13 for pneumococcal disease

Pfizer seeks FDA and EMA approval for expanded use of Prevnar 13 for pneumococcal disease

GAVI Alliance launches pneumonia vaccine project in Nicaragua

GAVI Alliance launches pneumonia vaccine project in Nicaragua

Prevenar 13 launched in first childhood immunization program for PD in Nicaragua

Prevenar 13 launched in first childhood immunization program for PD in Nicaragua

Is the decade long flirtation with vaccines over?

Is the decade long flirtation with vaccines over?

Rochester General Hospital Research Institute awarded $7M for Prevnar 13 study of ear infections in children

Rochester General Hospital Research Institute awarded $7M for Prevnar 13 study of ear infections in children

Johnson & Johnson in talks to buy Crucell

Johnson & Johnson in talks to buy Crucell

WHO grants prequalification status to pneumococcal vaccine, paving way for U.N. procurement

WHO grants prequalification status to pneumococcal vaccine, paving way for U.N. procurement

Pfizer's Prevenar 13-valent pneumococcal conjugate vaccine receives WHO prequalification

Pfizer's Prevenar 13-valent pneumococcal conjugate vaccine receives WHO prequalification